Impact of Ayurvedic drug Tinospora cordifolia in hyperlipidemia induced dysbiosis

Authors

  • Aarti Yadav Maharshi Dayanand University
  • Amey Shirolkar National Research Institute of Basic Ayurvedic Sciences
  • Rajesh Dabur Maharshi Dayanand University, Rohtak

Keywords:

probiotics, hyperlipidemia, Tinospora cordifolia, urinary metabolites, Mass spectrometry

Abstract

Gut microbiota broadly impacts human health, but urinary microbial metabolites remain largely undefined. The concentration of microbial metabolites can be directly correlated with microbial populations in the human gut to define disease states. Tinospora cordifolia (Willd.) Miers ex Hook. F. & Thoms is being used for ages in the Indian ayurvedic system of medicine and it has hypolipidemic and hypoglycaemic activity. Present study investigate the MS-based metabolomics variations of possible gut microbiota associated metabolites in hyperlipidemia (HPL) and HPL treated with Tinospora cordifolia extract (TCE) (TRT). Twenty-four HPL male patients and 10 age-matched controls (HLT) were enrolled. Early morning fasting blood and urine samples were collected on days 0 and 14th of TCE treatment and subjected to lipid profiling and Q-TOF-MS analysis. Multivariate analysis showed urinary levels of urocanic acid, hydroxyphenylacetate, linolenic acid, phenylpropionate, hypoxanthine, and indole acetate produced by Peptostreptococcs asaccharolyticus, Clostridium difficile, Faecalibacterium prausnitzii, Bifidobacterium, Subdoligranulum, Lactobacillus, Clostridium sporogenes, E. coli were depleted in HPL patients as compared to healthy controls. In contrast, levels of serotonin, acetylleucine, hippuric acid, and arabinitol were found to be increased (>2.0 fold, p<0.005). However, TCE treatment reverted the levels of these metabolites and therefore, gut microflora. Also, Cloacibacterium haliotis, Lactobacillus, Clostridium, and Bifidobacterium population decreased in HPL patients. Increased secretion of yeast or Candida albicans associated metabolites was because of their increased population. Hence, TCE treatment enhanced the growth of useful gut microbiota in hyperlipidemia patients.

Author Biography

  • Rajesh Dabur, Maharshi Dayanand University, Rohtak

    Deaprtment of BioChemistry
    M.D. University, Rohtak, Hr. India.

ayurvedic drug and gut microbiota

Published

2022-04-24

Issue

Section

Articles

How to Cite

Impact of Ayurvedic drug Tinospora cordifolia in hyperlipidemia induced dysbiosis. (2022). Chemical Biology Letters, 9(3), 363. https://pubs.thesciencein.org/journal/index.php/cbl/article/view/363

Similar Articles

1-10 of 18

You may also start an advanced similarity search for this article.